Overview

Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the rate of complete remission, as well as overall survival, in older patients with Acute Myeloid Leukemia (AML).
Phase:
Phase 2
Details
Lead Sponsor:
Eisai Inc.
Treatments:
Azacitidine
Decitabine